Heart transplantation has evolved as the criterion standard therapy for end-stage heart failure, but its efficacy is limited by the development of cardiac allograft vasculopathy (CAV), a unique and rapidly progressive form of atherosclerosis in heart transplant recipients. Here, we briefly review the key processes in the development of CAV during heart transplantation and highlight the roles of...

Heart transplantation is a treatment of choice for patients with severe heart failure. Infection transmission from donor to recipient remains prominent problem in organ transplantation. However, the risk SARS-CoV-2 nonlung still unclear. In this article we presented case 28-year-old pregnant woman who developed failure soon after recovery infection third trimester gestation. postpartum period, ...

heart failure is one of the leading causes of death worldwide. end stage disease often requires heart transplantation, which is hampered by donor organ shortage. tissue engineering represents a promising alternative approach for cardiac repair. for the generation of artificial heart muscle tissue several cell types, scaffold materials and bioreactor designs are under investigation. in this revi...

Recent significant improvement in surgical management of patients with univentricular palliations has resulted in an increasing number of patients with complex univentricular heart repairs surviving to heart transplantation. Heart transplantation in these patients can be challenging and may require extensive vascular reconstruction during transplantation. Herein, we describe the surgical recons...

EDITORIAL article Front. Cardiovasc. Med., 22 August 2023Sec. Heart Failure and Transplantation Volume 10 - 2023 | https://doi.org/10.3389/fcvm.2023.1275739

Heart failure (HF) is a prognostically unfavorable complication of cardiovascular diseases. The presented case report describes the management patient with severe progressive biventricular HF due to myocarditis, refractory therapy and requiring heart transplantation. Issues timely diagnosis feasibility radical surgical treatment are discussed.

BACKGROUND Heart transplantation is an uncommon treatment for unresectable and non-metastatic primary cardiac sarcomas, and the role of it is unclear. This study aims to offer a survival analysis of it. METHODS This study consists of 6 patients from our institution and 40 patients identified in a literature search who underwent heart transplantation for non-metastatic primary cardiac sarcomas...

Background—Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indica...